2/4
08:27 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% [Yahoo! Finance]
Medium
Report
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% [Yahoo! Finance]
2/3
08:13 pm
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
2/3
01:39 pm
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
2/3
10:46 am
aqst
Leerink sees ‘silver lining' in Aquestive CRL given defined path to approval [Yahoo! Finance]
Low
Report
Leerink sees ‘silver lining' in Aquestive CRL given defined path to approval [Yahoo! Finance]
2/3
10:13 am
aqst
Aquestive Therapeutics (NASDAQ:AQST) was given a new $6.00 price target on by analysts at Lake Street Capital.
Medium
Report
Aquestive Therapeutics (NASDAQ:AQST) was given a new $6.00 price target on by analysts at Lake Street Capital.
2/3
06:32 am
aqst
Aquestive receives FDA CRL for Anaphylm allergic reaction treatment [Yahoo! Finance]
Low
Report
Aquestive receives FDA CRL for Anaphylm allergic reaction treatment [Yahoo! Finance]
2/2
03:55 pm
aqst
Aquestive jumps despite receiving FDA Complete Response Letter [Seeking Alpha]
Neutral
Report
Aquestive jumps despite receiving FDA Complete Response Letter [Seeking Alpha]
2/2
01:24 pm
aqst
AQST Investors Have Opportunity to Join Aquestive Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Medium
Report
AQST Investors Have Opportunity to Join Aquestive Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
2/2
11:10 am
aqst
Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film Transcript [Seeking Alpha]
Low
Report
Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film Transcript [Seeking Alpha]
2/2
07:13 am
aqst
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™ [Yahoo! Finance]
High
Report
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™ [Yahoo! Finance]
2/2
07:00 am
aqst
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
High
Report
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
1/29
10:00 am
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/29
08:43 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/27
12:49 pm
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/25
08:24 pm
aqst
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/23
10:14 am
aqst
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/23
05:06 am
aqst
Aquestive Therapeutics (NASDAQ:AQST) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Aquestive Therapeutics (NASDAQ:AQST) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/22
10:00 am
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/20
04:38 pm
aqst
AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the Firm
Medium
Report
AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the Firm
1/20
01:05 pm
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/17
11:21 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Medium
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/16
07:24 pm
aqst
Jim Cramer: The whole Aquestive situation seems very ambiguous [CNBC]
Medium
Report
Jim Cramer: The whole Aquestive situation seems very ambiguous [CNBC]
1/15
10:00 am
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/14
10:22 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/13
04:42 pm
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST